Cargando…
PGC-1s in the Spotlight with Parkinson’s Disease
Parkinson’s disease is one of the most common neurodegenerative disorders worldwide, characterized by a progressive loss of dopaminergic neurons mainly localized in the substantia nigra pars compacta. In recent years, the detailed analyses of both genetic and idiopathic forms of the disease have led...
Autores principales: | Piccinin, Elena, Sardanelli, Anna Maria, Seibel, Peter, Moschetta, Antonio, Cocco, Tiziana, Villani, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036867/ https://www.ncbi.nlm.nih.gov/pubmed/33800548 http://dx.doi.org/10.3390/ijms22073487 |
Ejemplares similares
-
Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
por: Piccinin, Elena, et al.
Publicado: (2019) -
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure
por: Piccinin, Elena, et al.
Publicado: (2019) -
Intestinal Pgc1α ablation protects from liver steatosis and fibrosis
por: Piccinin, Elena, et al.
Publicado: (2023) -
Another One Bites the Gut: Nuclear Receptor LRH-1 in Intestinal Regeneration and Cancer
por: Zerlotin, Roberta, et al.
Publicado: (2021) -
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
por: Cariello, Marica, et al.
Publicado: (2021)